Posts Tagged: big Pharma

Blockbuster Drug

Posted by & filed under Accounting Information Systems, Accounting Principles, Advanced Accounting, All Articles, Auditing, Cost Accounting, Ethical Dilemma, Financial Accounting, Intermediate Accounting, Managerial Accounting, Uncategorized.

According to Bloomberg, Novartis AG is preparing for significant demand for its new gene therapy, a potential blockbuster targeting a disease that kills infants. Now the company is looking at the potential for installment payment plans for a treatment that could command a multimillion-dollar price. Questions: 1. At what price does Novartis estimate that the… Read more »

More Greed and Graft

Posted by & filed under Accounting Information Systems, Accounting Principles, Advanced Accounting, All Articles, Auditing, Cost Accounting, Ethical Dilemma, Financial Accounting, Income Taxes, Intermediate Accounting, International Accounting, Managerial Accounting.

According to the Washington Post, what started as an antitrust lawsuit brought by states over just two drugs in 2016 has exploded into an investigation of alleged price-fixing involving at least 16 companies and 300 drugs. Questions: 1. What was the “shorthand” between executives used for? Give an example. 2. According to the article, who… Read more »

Johnson & Johnson

Posted by & filed under Accounting Information Systems, Accounting Principles, Advanced Accounting, All Articles, Auditing, Cost Accounting, Ethical Dilemma, Financial Accounting, Financial Statement Analysis, Income Taxes, International Accounting, Managerial Accounting, Uncategorized.

According to Douglas House, a new analysis has been released that shows patients with type 2 diabetes (T2D) that are treated with Johnson & Johnson (JNJ) unit Janssen Pharmaceuticals’ INVOKANA (canagliflozin) experienced significantly less risk of cardiovascular (CV) death or hospitalization for heart failure (HHF). Questions: Based on the data, what is the reduction of… Read more »

The Dirty Little Secret about Big Pharma

Posted by & filed under Accounting Information Systems, Accounting Principles, Advanced Accounting, All Articles, Auditing, Cost Accounting, Ethical Dilemma, Financial Accounting, Intermediate Accounting, Managerial Accounting.

As the New York Times reports, when Big Pharma companies are under fire for skyrocketing drug prices, they would like you to believe that prices have to be so high to support research and development (R&D). But is that the truth? Questions: 1. What did the authors of the new study find that the 18… Read more »

The Business Model of Overstating Benefits: How Harmful or Ethical?

Posted by & filed under Accounting Principles, Advanced Accounting, Auditing, Financial Accounting, Financial Reporting and Analysis, Financial Statement Analysis, Fraud Accounting, IFRS, Intermediate Accounting, International Accounting, Video Updates.

It is estimated that between 50,000 to 100,000 patients died or had a heart attack as a result of taking the drug Advandia. For seven years, GlaxoSmithKline (GSK) failed to report data that indicated Advandia increases the risk of heart attack by 40%. As we reported back in July, in the biggest health care fraud… Read more »